logo
At MAHA Event, Trump Targets Corporate Lobbyists: ‘We Will Not Be Silenced'

At MAHA Event, Trump Targets Corporate Lobbyists: ‘We Will Not Be Silenced'

Epoch Times23-05-2025
WASHINGTON—President Donald Trump held an event on Thursday at the White House to highlight the first report from the Commission to Make America Healthy Again (MAHA), which focuses on improving childhood health.
He pledged to make Americans healthier and said his administration would not be intimidated by corporations.
'Unlike other administrations, we will not be silenced or intimidated by the corporate lobbyists or special interests,' Trump said during the White House event.
He called on his cabinet members to take decisive action against the interest groups.
'In some cases, it won't be nice or won't be pretty, but we have to do it,' he said. 'And we will not allow our public health system to be captured by the very industries it's supposed to oversee.'
Trump established the commission in February. Its first report,
Related Stories
5/22/2025
2/26/2025
The commission, chaired by Health and Human Services Secretary Robert F. Kennedy Jr., will make policy proposals over the next 80 days.
Trump shared some alarming findings from the report, noting that over 40 percent of American children have at least one chronic health condition. He highlighted a nearly 50 percent rise in childhood cancer rates since the 1970s, and pointed out that childhood obesity has surged from under 5 percent in the 1960s to more than 20 percent today. Autism rates, he added, have also climbed sharply, from 1 in 10,000 a few decades ago to 1 in 31.
'They really are alarming, unbelievable, terrible,' Trump said. 'There's something wrong, and we will not stop until we defeat the chronic disease epidemic in America.'
The report explores the root causes of increasing sickness among children, pointing to factors such as ultra-processed foods, overmedication, and exposure to toxic chemicals.
'Over the past few years, we've built an unstoppable coalition of moms and dads, doctors and young people and citizens of all backgrounds who have come together to protect our children, very importantly, keep the dangerous chemicals out of our food supplies, get toxic substances out of our environment,' Trump said.
'This movement has become very hot,' he said, referring to the MAHA movement.
He highlighted several actions already taken, including phasing out eight artificial food dyes, eliminating major conflicts of interest at the Food and Drug Administration, and approving Nebraska's SNAP waiver request to prevent taxpayer funds from contributing to childhood obesity.
Trump said requests are coming from other states as well.
At the event, Kennedy said he had never seen a president from either party willing to challenge the industry groups.
'My uncle tried to do this, but he was killed,' he said. 'And ever since then, we've been waiting for a president who would stand up and speak on behalf of the health of the American people.'
For too long, he said, the government has relied on biased research, while ignoring common sense or mothers' intuition.
Among the guests at the White House event was former House Speaker Newt Gingrich.
'It's a huge shift from a sick care system to a health care system,' Gingrich told The Epoch Times after the event.
'I think Bobby Kennedy really made clear when he talked about what his uncle would have done if he hadn't been killed. And so, he's sort of sitting here now, living out what his uncle would have done.'
Speaking after the event, scientist and physician Robert Malone called the White House meeting 'unprecedented.'
'It was an amazing presentation, and I know the team is fully committed,' he told The Epoch Times, referring to Trump's officials who pledged to address the health care crisis.
Meanwhile, some critics say that the report paints an overly bleak picture of children's diseases in the United States and unfairly targets vaccines.
Some groups, including the National Corn Growers Association, criticized the report.
'The Make America Healthy Again Report is filled with fear-based rather than science-based misinformation about pesticides,' the association
'We are deeply troubled that claims of this magnitude are being made without any scientific basis or regard for a long history of EPA expert evaluations of these products.'
Zachary Stieber contributed to this report.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

SelectQuote, Inc. Reports Fourth Quarter of Fiscal Year 2025 Results
SelectQuote, Inc. Reports Fourth Quarter of Fiscal Year 2025 Results

Business Wire

time8 minutes ago

  • Business Wire

SelectQuote, Inc. Reports Fourth Quarter of Fiscal Year 2025 Results

OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT) reported consolidated revenue for the fourth quarter of fiscal year 2025 of $345.1 million compared to consolidated revenue for the fourth quarter of fiscal year 2024 of $307.2 million. Consolidated net income for the fourth quarter of fiscal year 2025 was $12.9 million compared to consolidated net loss for the fourth quarter of fiscal year 2024 of $31.0 million. Finally, consolidated Adjusted EBITDA* for the fourth quarter of fiscal year 2025 was $2.7 million compared to consolidated Adjusted EBITDA* for the fourth quarter of fiscal year 2024 of $14.4 million. Tim Danker, SelectQuote Chief Executive Officer, commented 'The strength of our holistic healthcare services model was broadly exhibited in fiscal 2025, and we firmly believe the years ahead will increasingly drive substantial value for each of our stakeholders. Policyholders and patients will continue to benefit from our information advantage through tailored advice and healthcare solutions, which ultimately result in better health outcomes. Our insurance and healthcare service partners benefit from better treatment fit and adherence, which eliminates waste and serves to ease the historical trend of rising healthcare costs for Americans. Additionally, we believe our shareholders will benefit as SelectQuote's diverse breadth of revenues drive increasing cash flow, which will accelerate and compound with new growth initiatives in the future.' Mr. Danker continued, 'We are proud to have delivered financial results well in excess of our initial expectations for the 3rd consecutive year. Over that period, our Adjusted EBITDA results have outperformed our forecasts by more than 20% each year. Our leadership and workforce have accomplished these results through significant change in Medicare Advantage in each year. We credit the talent and hard work of our people and are exceedingly proud of the track record SelectQuote has built as an agile, innovative and reliable source of value for Americans seeking healthcare that best fits their needs.' * See 'Non-GAAP Financial Measures' below. Segment Results We currently have three reportable segments: 1) Senior, 2) Healthcare Services and 3) Life. The performance measures of the segments include total revenue and Adjusted EBITDA.* Costs of commissions and other services revenue, cost of goods sold-pharmacy revenue, marketing and advertising, selling, general, and administrative, and technical development operating expenses that are directly attributable to a segment are reported within the applicable segment. Indirect costs of revenue, marketing and advertising, selling, general, and administrative, and technical development operating expenses are allocated to each segment based on varying metrics such as headcount. Adjusted EBITDA is our segment profit measure to evaluate the operating performance of our business. We define Adjusted EBITDA as income (loss) before income tax expense (benefit) plus: (i) interest expense, net; (ii) depreciation and amortization; (iii) share-based compensation; (iv) goodwill, long-lived asset, and intangible assets impairments; (v) transaction costs; (vi) loss on disposal of property, equipment and software, net; (vii) other non-recurring expenses and income; (viii) changes in fair value of warrant liabilities. Adjusted EBITDA margin is calculated as Adjusted EBITDA divided by revenue. Senior Financial Results The following table provides the financial results for the Senior segment for the periods presented: Operating Metrics Submitted Policies Submitted policies are counted when an individual completes an application with our licensed agent and provides authorization to the agent to submit the application to the insurance carrier partner. The applicant may have additional actions to take before the application will be reviewed by the insurance carrier. The following table shows the number of submitted policies for the periods presented: * See 'Non-GAAP Financial Measures' below. Approved Policies Approved policies represents the number of submitted policies that were approved by our insurance carrier partners for the identified product during the indicated period. Not all approved policies will go in force. The following table shows the number of approved policies for the periods presented: Lifetime Value of Commissions per Approved Policy Lifetime value of commissions per approved policy represents commissions estimated to be collected over the estimated life of an approved policy based on multiple factors, including but not limited to, contracted commission rates, carrier mix and expected policy persistency with applied constraints. The lifetime value of commissions per approved policy is equal to the sum of the commission revenue due upon the initial sale of a policy, and when applicable, an estimate of future renewal commissions. The following table shows the lifetime value of commissions per approved policy for the periods presented: Healthcare Services Financial Results The following table provides the financial results for the Healthcare Services segment for the periods presented: Three Months Ended June 30, Year Ended June 30, (in thousands) 2025 2024 % Change 2025 2024 % Change Revenue $ 214,028 $ 145,223 47 % $ 742,705 $ 478,508 55 % Adjusted EBITDA* 11,853 909 1,204 % 25,387 7,821 225 % Adjusted EBITDA Margin* 6 % 1 % 3 % 2 % Expand Operating Metrics Members The total number of SelectRx members represents the amount of active customers to which an order has been shipped and the prescriptions per day represents the total average prescriptions shipped per business day. These two metrics are the primary drivers of revenue for Healthcare Services. * See 'Non-GAAP Financial Measures' below. The following table shows the total number of SelectRx members as of the periods presented: The total number of SelectRx members increased by 31% as of June 30, 2025, compared to June 30, 2024, due to our strategy to grow SelectRx membership. The following table shows the average prescriptions shipped per day for the periods presented: Combined Senior and Healthcare Services - Consumer Per Unit Economics Combined Senior and Healthcare Services consumer per unit economics represents total MA and MS commissions; other product commissions; other revenues, including revenues from Healthcare Services; and operating expenses associated with Senior and Healthcare Services, each shown per number of approved MA and MS policies over a given time period. Management assesses the business on a per-unit basis to help ensure that the revenue opportunity associated with a successful policy sale is attractive relative to the marketing acquisition cost. Because not all acquired leads result in a successful policy sale, all per-policy metrics are based on approved policies, which is the measure that triggers revenue recognition. The MA and MS commission per MA/MS policy represents the LTV for policies sold in the period. Other commission per MA/MS policy represents the LTV for other products sold in the period, including DVH prescription drug plan, and other products, which management views as additional commission revenue on our agents' core function of MA/MS policy sales. Pharmacy revenue per MA/MS policy represents revenue from SelectRx, and other revenue per MA/MS policy represents revenue from Population Health, production bonuses, marketing development funds, lead generation revenue, and adjustments from the Company's reassessment of its cohorts' transaction prices. Total operating expenses per MA/MS policy represents all of the operating expenses within Senior and Healthcare Services. The revenue to customer acquisition cost ('CAC') multiple represents total revenue as a multiple of total marketing acquisition cost, which represents the direct costs of acquiring leads. These costs are included in marketing and advertising expense within the total operating expenses per MA/MS policy. The following table shows combined Senior and Healthcare Services consumer per unit economics for the periods presented. Based on the seasonality of Senior and the fluctuations between quarters, we believe that the most relevant view of per unit economics is on a rolling 12-month basis. All per MA/MS policy metrics below are based on the sum of approved MA/MS policies, as both products have similar commission profiles. Total revenue per MA/MS policy increased 22% for the twelve months ended June 30, 2025, compared to the twelve months ended June 30, 2024, primarily due to the increase in pharmacy revenue. Total operating expenses per MA/MS policy increased 27% for the twelve months ended June 30, 2025, compared to the twelve months ended June 30, 2024, driven by an increase in cost of goods sold-pharmacy revenue for Healthcare Services due to the growth of the business. Life Financial Results The following table provides the financial results for the Life segment for the periods presented: Operating Metrics Life premium represents the total premium value for all policies that were approved by the relevant insurance carrier partner and for which the policy document was sent to the policyholder and payment information was received by the relevant insurance carrier partner during the indicated period. Because our commissions are earned based on a percentage of total premium, total premium volume for a given period is the key driver of revenue for our Life segment. The following table shows term and final expense premiums for the periods presented: * See 'Non-GAAP Financial Measures' below. Earnings Conference Call SelectQuote, Inc. will host a conference call with the investment community on August 21, 2025, beginning at 8:30 a.m. ET. To register for this conference call, please use this link: After registering, a confirmation will be sent via email, including dial-in details and unique conference call codes for entry. Registration is open through the live call, but to ensure you are connected for the full call we suggest registering at least 10 minutes before the start of the call. The event will also be webcasted live via our investor relations website Non-GAAP Financial Measures This release includes certain non-GAAP financial measures intended to supplement, not substitute for, comparable GAAP measures. To supplement our financial statements presented in accordance with GAAP and to provide investors with additional information regarding our GAAP financial results, we have presented in this release Adjusted EBITDA, which is a non-GAAP financial measure. This non-GAAP financial measure is not based on any standardized methodology prescribed by GAAP and is not necessarily comparable to any similarly titled measure presented by other companies. We define Adjusted EBITDA as net income (loss) before income tax expense (benefit), plus interest expense, depreciation and amortization, changes in fair value of warrant liabilities, and certain add-backs for non-cash or non-recurring expenses, including restructuring and share-based compensation expenses. The most directly comparable GAAP measure is net income (loss) before income tax expense (benefit). We monitor and have presented in this release Adjusted EBITDA because it is a key measure used by our management and Board of Directors to understand and evaluate our operating performance, establish budgets, and develop operational goals for managing our business. In particular, we believe that excluding the impact of these expenses in calculating Adjusted EBITDA can provide a useful measure for period-to-period comparisons of our core operating performance. Reconciliations of net income (loss) before income tax expense (benefit) to Adjusted EBITDA are presented below beginning on page 12. The Company is unable to provide a quantitative reconciliation of forward-looking Adjusted EBITDA to its most directly comparable GAAP measure without unreasonable effort because it is not possible to predict certain information included in the calculation of such GAAP measure, including the fair value of outstanding warrants to purchase shares of the Company's common stock. The unavailable information could have a significant impact on the Company's GAAP financial results. Forward Looking Statements This release contains forward-looking statements. These forward-looking statements reflect our current views with respect to, among other things, future events and our financial performance. These statements are often, but not always, made through the use of words or phrases such as 'may,' 'should,' 'could,' 'predict,' 'potential,' 'believe,' 'will likely result,' 'expect,' 'continue,' 'will,' 'anticipate,' 'seek,' 'estimate,' 'intend,' 'plan,' 'projection,' 'would' and 'outlook,' or the negative version of those words or other comparable words or phrases of a future or forward-looking nature. These forward-looking statements are not historical facts and are based on current expectations, estimates and projections about our industry, management's beliefs and certain assumptions made by management, many of which, by their nature, are inherently uncertain and beyond our control. Accordingly, we caution you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions and uncertainties that are difficult to predict. Although we believe that the expectations reflected in these forward-looking statements are reasonable as of the date made, actual results may prove to be materially different from the results expressed or implied by the forward-looking statements. There are or will be important factors that could cause our actual results to differ materially from those indicated in these forward-looking statements, including, but not limited to, the following: our reliance on a limited number of insurance carrier partners and any potential termination of those relationships or failure to develop new relationships; existing and future laws and regulations affecting the health insurance market; changes in health insurance products offered by our insurance carrier partners and the health insurance market generally; insurance carriers offering products and services directly to consumers; changes to commissions paid by insurance carriers and underwriting practices; competition with brokers, exclusively online brokers and carriers who opt to sell policies directly to consumers; competition from government-run health insurance exchanges; developments in the U.S. health insurance system; our dependence on revenue from carriers in our senior segment and downturns in the senior health as well as life, automotive and home insurance industries; our ability to develop new offerings and penetrate new vertical markets; risks from third-party products; failure to enroll individuals during the Medicare annual enrollment period; our ability to attract, integrate and retain qualified personnel; our dependence on lead providers and ability to compete for leads; failure to obtain and/or convert sales leads to actual sales of insurance policies; access to data from consumers and insurance carriers; accuracy of information provided from and to consumers during the insurance shopping process; cost-effective advertisement through internet search engines; ability to contact consumers and market products by telephone; global economic conditions, including inflation and tariffs; disruption to operations as a result of future acquisitions; significant estimates and assumptions in the preparation of our financial statements; impairment of goodwill; existing or potential litigation and other legal proceedings or inquiries, including the Department of Justice action alleging violations of the federal False Claims Act; our existing and future indebtedness; our ability to maintain compliance with our debt covenants; access to additional capital; failure to protect our intellectual property and our brand; fluctuations in our financial results caused by seasonality; accuracy and timeliness of commissions reports from insurance carriers; timing of insurance carriers' approval and payment practices; factors that impact our estimate of the constrained lifetime value of commissions per policyholder; changes in accounting rules, tax legislation and other legislation; disruptions or failures of our technological infrastructure and platform; failure to maintain relationships with third-party service providers; cybersecurity breaches or other attacks involving our systems or those of our insurance carrier partners or third-party service providers; our ability to protect consumer information and other data; failure to market and sell Medicare plans effectively or in compliance with laws; and other factors related to our pharmacy business, including manufacturing or supply chain disruptions, access to and demand for prescription drugs, contractual reimbursement rates, and regulatory changes or other industry developments that may affect our pharmacy operations. For a further discussion of these and other risk factors that could impact our future results and performance, see the section entitled 'Risk Factors' in our Annual Report on Form 10-K for the fiscal year ended June 30, 2025 (the 'Annual Report') and subsequent periodic reports filed by us with the Securities and Exchange Commission. Accordingly, you should not place undue reliance on any such forward-looking statements. Any forward-looking statement speaks only as of the date on which it is made, and, except as otherwise required by law, we do not undertake any obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise.. About SelectQuote: Founded in 1985, SelectQuote (NYSE: SLQT) pioneered the model of providing unbiased comparisons from multiple, highly-rated insurance companies, allowing consumers to choose the policy and terms that best meet their unique needs. Two foundational pillars underpin SelectQuote's success: a strong force of highly-trained and skilled agents who provide a consultative needs analysis for every consumer, and proprietary technology that sources and routes high-quality leads. Today, the Company operates an ecosystem offering high touchpoints for consumers across insurance, pharmacy, and virtual care. With an ecosystem offering engagement points for consumers across insurance, Medicare, pharmacy, and value-based care, the company now has three core business lines: SelectQuote Senior, SelectQuote Healthcare Services, and SelectQuote Life. SelectQuote Senior serves the needs of a demographic that sees around 10,000 people turn 65 each day with a range of Medicare Advantage and Medicare Supplement plans. SelectQuote Healthcare Services is comprised of the SelectRx Pharmacy, a Patient-Centered Pharmacy Home™ (PCPH) accredited pharmacy, SelectPatient Management, a provider of chronic care management services, and Healthcare Select which proactively connects consumers with a wide breadth of healthcare services supporting their needs. Source: SelectQuote, Inc. June 30, 2024 ASSETS CURRENT ASSETS: Cash, cash equivalents, and restricted cash $ 35,733 $ 42,690 Accounts receivable, net of allowances of $11.8 million and $8.2 million, respectively 151,388 150,035 Commissions receivable-current 132,077 119,871 Other current assets 21,844 20,327 Total current assets 341,042 332,923 COMMISSIONS RECEIVABLE—Net 818,751 761,446 PROPERTY AND EQUIPMENT—Net 14,577 18,973 SOFTWARE—Net 15,060 13,978 OPERATING LEASE RIGHT-OF-USE ASSETS 24,635 23,437 INTANGIBLE ASSETS—Net 1,973 10,194 GOODWILL 29,438 29,438 OTHER ASSETS 3,880 3,519 TOTAL ASSETS $ 1,249,356 $ 1,193,908 LIABILITIES, PREFERRED STOCK, AND SHAREHOLDERS' EQUITY CURRENT LIABILITIES: Accounts payable $ 59,205 $ 36,587 Accrued expenses 13,856 16,904 Accrued compensation and benefits 58,788 57,594 Operating lease liabilities—current 4,820 4,709 Current portion of long-term debt 68,523 45,854 Contract liabilities 698 8,066 Other current liabilities 7,020 4,873 Total current liabilities 212,910 174,587 LONG-TERM DEBT, NET—less current portion 316,589 637,480 DEFERRED INCOME TAXES 37,872 37,478 OPERATING LEASE LIABILITIES 25,982 25,685 OTHER LIABILITIES 80,485 1,877 Total liabilities 673,838 877,107 COMMITMENTS AND CONTINGENCIES PREFERRED STOCK: Senior Non-Convertible Preferred Stock, $0.01 par value, 350,000 shares and no shares issued and outstanding as of June 30, 2025 and June 30, 2024, respectively, current liquidation preference of $367.1 million and $0.0 million as of June 30, 2025 and June 30, 2024, respectively 224,374 — SHAREHOLDERS' EQUITY: Common stock, $0.01 par value 1,728 1,694 Additional paid-in capital 571,605 580,764 Accumulated deficit (222,189 ) (269,769 ) Accumulated other comprehensive income — 4,112 Total shareholders' equity 351,144 316,801 TOTAL LIABILITIES, PREFERRED STOCK, AND SHAREHOLDERS' EQUITY $ 1,249,356 $ 1,193,908 Expand SELECTQUOTE, INC. AND SUBSIDIARIES (Unaudited) (In thousands) Three Months Ended June 30, Year Ended June 30, 2025 2024 2025 2024 REVENUE: Commissions and other services $ 134,503 $ 165,656 $ 797,841 $ 856,923 Pharmacy 210,599 141,552 728,753 464,853 Total revenue 345,102 307,208 1,526,594 1,321,776 OPERATING COSTS AND EXPENSES: Cost of commissions and other services revenue 58,844 64,548 305,127 318,798 Cost of goods sold—pharmacy revenue 182,312 120,644 630,340 405,004 Marketing and advertising 65,283 70,181 319,505 358,858 Selling, general, and administrative 9,594 43,993 164,442 141,042 Technical development 41,591 9,233 38,681 33,524 Total operating costs and expenses 357,624 308,599 1,458,095 1,257,226 INCOME (LOSS) FROM OPERATIONS (12,522 ) (1,391 ) 68,499 64,550 INTEREST EXPENSE, NET (12,226 ) (23,409 ) (79,385 ) (93,551 ) CHANGE IN FAIR VALUE OF WARRANTS 34,181 — 59,525 — OTHER EXPENSE, NET (58 ) (15 ) (128 ) (65 ) INCOME (LOSS) BEFORE INCOME TAX EXPENSE (BENEFIT) 9,375 (24,815 ) 48,511 (29,066 ) INCOME TAX EXPENSE (BENEFIT) (3,493 ) 6,202 931 5,059 NET INCOME (LOSS) $ 12,868 $ (31,017 ) $ 47,580 $ (34,125 ) Senior Non-Convertible Preferred Stock accumulated dividends and accretion $ (16,762 ) $ — $ (22,548 ) $ — NET INCOME (LOSS) ATTRIBUTABLE TO COMMON SHAREHOLDERS PER SHARE: Basic $ (0.02 ) $ (0.18 ) $ 0.14 $ (0.20 ) Diluted $ (0.02 ) $ (0.18 ) $ 0.01 $ (0.20 ) WEIGHTED-AVERAGE COMMON STOCK OUTSTANDING USED IN PER SHARE AMOUNTS: Basic 184,201 169,204 176,148 168,519 OTHER COMPREHENSIVE LOSS NET OF TAX: Change in cash flow hedge — (2,364 ) (4,112 ) (9,567 ) OTHER COMPREHENSIVE LOSS — (2,364 ) (4,112 ) (9,567 ) COMPREHENSIVE INCOME (LOSS) $ 12,868 $ (33,381 ) $ 43,468 $ (43,692 ) Expand SELECTQUOTE, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (In thousands) Three Months Ended June 30, Year Ended June 30, 2025 2024 2025 2024 CASH FLOWS FROM OPERATING ACTIVITIES: Net income (loss) $ 12,868 $ (31,017 ) $ 47,580 $ (34,125 ) Adjustments to reconcile net income (loss) to net cash, cash equivalents, and restricted cash used in operating activities: Depreciation and amortization 4,876 6,407 20,460 24,998 Loss on disposal of property, equipment, and software 80 523 240 536 Impairment of long-lived assets 4,209 — 4,209 — Share-based compensation expense 4,852 3,304 18,357 13,816 Deferred income taxes (2,576 ) 3,314 1,849 1,163 Amortization of debt issuance costs and debt discount 1,367 1,279 5,247 6,142 Write-off of debt issuance costs — — 93 293 Accrued interest payable in kind 713 5,254 14,013 19,577 Change in fair value of warrants (34,181 ) — (59,525 ) — Non-cash lease expense 1,072 404 3,922 2,349 Bad debt expense — — 4,203 — Changes in operating assets and liabilities: Accounts receivable, net 33,491 103,722 (5,555 ) 5,203 Commissions receivable (35,745 ) (48,194 ) (69,510 ) (40,819 ) Other assets (5,938 ) 653 (6,282 ) (1,967 ) Accounts payable and accrued expenses (21,936 ) (28,726 ) 19,226 7,347 Operating lease liabilities (1,137 ) (1,095 ) (4,711 ) (4,897 ) Other liabilities 503 4,167 (5,482 ) 15,620 Net cash provided by (used in) operating activities (37,482 ) 19,995 (11,666 ) 15,236 CASH FLOWS FROM INVESTING ACTIVITIES: Purchases of property and equipment (501 ) (268 ) (2,191 ) (3,382 ) Proceeds from sales of property and equipment — — — 253 Purchases of software and capitalized software development costs (2,610 ) (2,219 ) (9,123 ) (8,284 ) Acquisition of business — (3,433 ) — (3,433 ) Net cash used in investing activities (3,111 ) (5,920 ) (11,314 ) (14,846 ) CASH FLOWS FROM FINANCING ACTIVITIES: Proceeds from revolving line of credit — — 166,900 — Payments on revolving line of credit — — (166,900 ) — Payments on Term Loans (3,573 ) (8,471 ) (388,216 ) (38,883 ) Proceeds from ABS Notes — — 99,095 — Payments on ABS Notes (4,855 ) — (16,577 ) — Payments on other debt (108 ) (37 ) (312 ) (149 ) Proceeds from common stock options exercised and employee stock purchase plan (14 ) 74 98 81 Proceeds from issuance of Senior Non-Convertible Preferred Stock — — 337,855 — Senior Non-Convertible Preferred Stock issuance costs — — (7,076 ) — Payments of tax withholdings related to net share settlement of equity awards (13 ) (1 ) (5,032 ) (374 ) Payments of debt issuance costs — (758 ) (2,479 ) (1,531 ) Net cash provided by (used in) financing activities (8,563 ) (9,193 ) 17,356 (40,856 ) (49,156 ) 4,882 (5,624 ) (40,466 ) CASH, CASH EQUIVALENTS AND RESTRICTED CASH —Beginning of period 86,222 37,808 42,690 83,156 CASH, CASH EQUIVALENTS AND RESTRICTED CASH —End of period $ 37,066 $ 42,690 $ 37,066 $ 42,690 Expand Three Months Ended June 30, 2025 (in thousands) Senior Healthcare Services Life Total Less: Cost of commissions and other services revenue (32,391 ) (5,536 ) (18,020 ) Cost of goods sold - pharmacy revenue — (180,988 ) — Marketing expense (41,752 ) (1,950 ) (22,813 ) Technical development — (495 ) — Selling, general, and administrative (599 ) (13,206 ) (229 ) Adjusted Segment EBITDA 7,722 11,853 6,922 26,497 Reconciliation of total segment Adjusted EBITDA All other Adjusted EBITDA 950 Corporate (24,753 ) Share-based compensation expense (4,852 ) Transaction costs (1,257 ) Depreciation and amortization (4,876 ) Loss on disposal of property, equipment, and software, net (80 ) Impairment of long-lived assets (4,209 ) Change in fair value of warrants 34,181 Interest expense, net (12,226 ) Income before income tax expense (benefit) $ 9,375 Expand Three Months Ended June 30, 2024 (in thousands) Senior Healthcare Services Life Total Total revenue from reportable segments $ 114,143 $ 145,223 $ 42,074 $ 301,440 Less: Cost of commissions and other services revenue (37,534 ) (5,025 ) (15,287 ) Cost of goods sold - pharmacy revenue — (119,520 ) — Marketing expense (48,138 ) (1,700 ) (19,279 ) Technical development — (835 ) — Selling, general, and administrative (599 ) (17,234 ) (291 ) Adjusted Segment EBITDA 27,872 909 7,217 35,998 Reconciliation of total segment Adjusted EBITDA All other Adjusted EBITDA 2,474 Corporate (24,115 ) Share-based compensation expense (3,304 ) Transaction costs (5,529 ) Depreciation and amortization (6,407 ) Loss on disposal of property, equipment, and software, net (523 ) Interest expense, net (23,409 ) Loss before income tax expense (benefit) $ (24,815 ) Expand SELECTQUOTE, INC. AND SUBSIDIARIES Adjusted EBITDA to Income (Loss) before income tax expense (benefit) Reconciliation (Unaudited) Year Ended June 30, 2025 Total revenue from reportable segments $ 600,393 $ 742,705 $ 172,978 $ 1,516,076 Less: Cost of commissions and other services revenue (201,933 ) (25,163 ) (65,047 ) Cost of goods sold - pharmacy revenue — (625,389 ) — Marketing expense (234,335 ) (8,038 ) (80,269 ) Technical development — (2,187 ) — Selling, general, and administrative (2,454 ) (56,541 ) (993 ) Adjusted Segment EBITDA 161,671 25,387 26,669 213,727 Reconciliation of total segment Adjusted EBITDA All other Adjusted EBITDA 10,597 Corporate (98,070 ) Share-based compensation expense (18,357 ) Transaction costs (14,617 ) Depreciation and amortization (20,460 ) Loss on disposal of property, equipment, and software, net (240 ) Impairment of long-lived assets (4,209 ) Change in fair value of warrants 59,525 Interest expense, net (79,385 ) Income before income tax expense (benefit) $ 48,511 Expand Year Ended June 30, 2024 (in thousands) Senior Healthcare Services Life Total Total revenue from reportable segments $ 655,849 $ 478,508 $ 157,930 $ 1,292,287 Less: Cost of commissions and other services revenue (216,348 ) (17,438 ) (60,017 ) Cost of goods sold - pharmacy revenue — (400,821 ) — Marketing expense (269,867 ) (6,260 ) (76,513 ) Technical development — (915 ) — Selling, general, and administrative (2,890 ) (45,253 ) (1,236 ) Adjusted Segment EBITDA 166,744 7,821 20,164 194,729 Reconciliation of total segment Adjusted EBITDA All other Adjusted EBITDA 14,127 Corporate (91,863 ) Share-based compensation expense (13,816 ) Transaction costs (13,158 ) Depreciation and amortization (24,998 ) Loss on disposal of property, equipment, and software, net (536 ) Interest expense, net (93,551 ) Loss before income tax expense (benefit) $ (29,066 ) Expand

Tourist hospitalized after terrifying attack at Florida beach: 'Severe lacerations to the upper arm area'
Tourist hospitalized after terrifying attack at Florida beach: 'Severe lacerations to the upper arm area'

Yahoo

time31 minutes ago

  • Yahoo

Tourist hospitalized after terrifying attack at Florida beach: 'Severe lacerations to the upper arm area'

Tourist hospitalized after terrifying attack at Florida beach: 'Severe lacerations to the upper arm area' A French Canadian is recovering from a shark bite in Florida, according to USA Today. What's happening? A tourist in his 40s suffered "severe lacerations to the upper arm area," said Hollywood Fire Rescue and Beach Safety's Chai Kauffman, per USA Today. He was in the area visiting friends and family. At the time of the attack, he was in chest-deep water with a friend. Following the bite, he was able to make it back to shore. Beach visitors provided him with aid until an ambulance arrived. While this tourist was minding his own business, others have antagonized sharks, leading to truly brutal results. Why are shark attacks important? Shark attacks are incredibly rare. There have been 38 shark bites on humans in 2025 so far, 12 of which were in the U.S., 7 of which were in Florida, Tracking Sharks revealed. Only eight of the global attacks have been fatal. This has been a slight uptick compared to previous years, but the numbers are still small. While sharks have a threatening reputation, they play a major ecosystem role. As apex predators, they keep prey species in check. Without sharks, those populations could explode and overrun delicate marine ecosystems, as the National Oceanic and Atmospheric Administration explained. Shark populations are actually in decline. Overfishing, poaching, and habitat degradation are some of the primary drivers for this drop. Naturally slow birth rates combined with these downward pressures have resulted in an 80% drop in shark populations between 1975 and 2009, Mongabay reported. What's being done about shark attacks? The Florida Fish and Wildlife Conservation Commission has a series of safety tips to lower the odds of shark encounters. These tips include staying in groups, avoiding being in the water at night or twilight, not wearing shiny jewelry, and minimizing excessive splashing. As for shark populations, researchers are taking local action by increasing tagging efforts to monitor population numbers and movement trends. This data can better inform protection measures. Do you think Americans use too much plastic? Absolutely Only in some states We're getting better We're doing fine Click your choice to see results and speak your mind. Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet.

NationsBenefits and Tops Friendly Markets Partner to Advance Food as Medicine Access Across Upstate New York, Pennsylvania, and Vermont
NationsBenefits and Tops Friendly Markets Partner to Advance Food as Medicine Access Across Upstate New York, Pennsylvania, and Vermont

Business Wire

time36 minutes ago

  • Business Wire

NationsBenefits and Tops Friendly Markets Partner to Advance Food as Medicine Access Across Upstate New York, Pennsylvania, and Vermont

PLANTATION, Fla.--(BUSINESS WIRE)-- NationsBenefits®, a leading provider of supplemental-benefit and healthcare-fintech solutions, today announced a new retail integration with Tops Friendly Markets, the neighborhood grocer that operates 147 full-service supermarkets across Upstate New York, northern Pennsylvania, and Vermont. Through this partnership, health plan members can immediately use their NationsBenefits Benefits Mastercard® Prepaid Card* at all Tops locations to purchase fresh produce, pantry staples, and over-the-counter wellness essentials with each transaction validated in real time by NationsBenefits' Basket Adjudication Service (BAS). 'For more than 60 years, Tops Friendly Markets has anchored community health,' said Michael Parker, Co‑CEO of NationsBenefits. 'Integrating their stores into our supplemental‑benefit network brings healthier, benefits‑eligible foods within easy reach..." Share 'For more than sixty years, Tops Friendly Markets has anchored community health,' said Michael Parker, Co-CEO of NationsBenefits. 'Integrating their stores into our supplemental-benefit network brings healthier, benefits-eligible foods within easy reach of families who once faced long drives or limited choices.' Food insecurity remains a critical challenge, with nearly one in four New York adults, particularly in rural counties, lacking reliable access to nutritious food. Nationwide, nearly 19 million Americans live in low-income, low-access census tracts, often more than ten miles from the nearest supermarket, while diabetes rates run up to 17 percent higher in rural areas than in urban centers. By integrating our Basket Adjudication Service (BAS) at every Tops checkout, NationsBenefits transforms routine grocery trips into Food as Medicine opportunities, letting members redeem supplemental benefits on culturally familiar, locally sourced items. Our real-time basket-analytics engine captures each eligible transaction at checkout, delivering ZIP-code-level purchase insights that enable health plans to fine-tune benefits and launch precisely targeted community outreach. "Feeding our neighborhoods well has always been at the heart of Tops," said Ron Ferri, President of Tops Friendly Markets. "By joining the NationsBenefits retail network, we can now place affordable, nutritious options directly in front of eligible shoppers at the very moment they fill their baskets." Tops remains focused on delivering an exceptional experience rooted in fresh, high-quality products and services, and innovative programs. With a continued focus on meeting customers where they are, the company is helping support healthier lifestyles, simplify shopping, and make every trip to the store more rewarding. 'Tops Friendly Markets has been ensuring access to high quality fresh foods and cutting-edge Pharmacy services to generations of customers,' said Ellie Wilson, MS, RDN, FAND, manager of lifestyle and wellness for Tops. 'We strive to innovate and explore how we can best serve shoppers seeking wellness options, with a spotlight on natural, organic and gluten free items, partnerships with local produce farmers, and now, direct access to insurance benefits that empower healthy purchases.' Peer-reviewed research shows that medically tailored meals and broader Food as Medicine programs can cut annual hospitalizations by 47% while managing overall healthcare costs by 16%. Leveraging this proprietary BAS technology, health plans also gain real-world, transaction-level insights that illuminate nutrition gaps by geography or chronic-condition cohort, guide ZIP-code-specific preventive initiatives such as A1C screenings or dietitian consults, and power personalized rewards that reinforce healthy shopping habits, improve member experience and engagement. Together, we're transforming everyday grocery visits into measurable outcomes that improve the health and wellness of individuals. About NationsBenefits NationsBenefits® is a leading provider of supplemental benefits, fintech solutions, and outcome improvement solutions to the healthcare industry. NationsBenefits partners with managed care organizations to provide innovative healthcare, data analytics, gap closure, and fintech solutions aimed at driving growth, reducing costs, and delighting members. Combining its cutting-edge technology with targeted retailer partnerships, NationsBenefits empowers health plans to deliver impactful supplemental benefits to optimize member experiences and drive better health outcomes. By simplifying processes to make smarter choices and expanding access to benefits solutions, NationsBenefits aims to improve each of its members' quality of life through its revolutionary and comprehensive suite of offerings. To learn more, visit About Tops Friendly Markets Based in Williamsville, NY, Tops Markets currently operates 152 grocery stores in New York, Pennsylvania, and Vermont, including one that is run by a franchisee. As the largest private, for-profit employer in Western New York, with over 14,000 associates, the company is dedicated to providing sustainably sourced, high-quality products, while helping its communities flourish via support for programs that eradicate hunger and disease, educate youth, and reduce environmental waste and energy consumption. For more information, visit

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store